Disitamab vedotin is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). This reagent consists of a monoclonal antibody linked through a cleavable connector to the cytotoxic drug Monomethyl auristatin E (MMAE). Disitamab vedotin is designed to enhance antitumor immunity and is applicable in cancer research, particularly in studies focused on HER2-positive malignancies.
Disitamab vedotin is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). This reagent consists of a monoclonal antibody linked through a cleavable connector to the cytotoxic drug Monomethyl auristatin E (MMAE). Disitamab vedotin is designed to enhance antitumor immunity and is applicable in cancer research, particularly in studies focused on HER2-positive malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
